CLPT Price / Book | ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

ClearPoint Neuro, Inc. price/book ratio for the quarter ending 2026-06-30 was 50.5, a 194.02% increase year-over-year.
ClearPoint Neuro, Inc. price/book ratio for the quarter ending 2026-03-31 was 14.47, a 13.08% decline year-over-year.
ClearPoint Neuro, Inc. price/book ratio for the quarter ending 2025-12-31 was 14.34, a 14.26% decline year-over-year.
ClearPoint Neuro, Inc. price/book ratio for the quarter ending 2025-09-30 was 38.93, a 265.09% increase year-over-year.
ClearPoint Neuro, Inc. price/book ratio for fiscal 2026 was 50.5.
ClearPoint Neuro, Inc. price/book ratio for fiscal 2025 was 14.34, a 14.26% decline from fiscal 2024.
ClearPoint Neuro, Inc. price/book ratio for fiscal 2024 was 16.73, a 111.61% increase from fiscal 2023.
ClearPoint Neuro, Inc. price/book ratio for fiscal 2023 was 7.91, a 40.08% increase from fiscal 2022.

Available history: 2012-06-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	50.5	$544.18M	$10.78M
2026-03-31	14.47	$272.58M	$18.84M
2025-12-31	14.34	$401.91M	$28.02M
2025-09-30	38.93	$618.03M	$15.87M
2025-06-30	17.18	$339.09M	$19.74M
2025-03-31	16.65	$332.68M	$19.99M
2024-12-31	16.73	$424.76M	$25.39M
2024-09-30	10.66	$309.27M	$29M
2024-06-30	4.63	$148.7M	$32.13M
2024-03-31	5.39	$186.43M	$34.58M
2023-12-31	7.91	$167.39M	$21.17M
2023-09-30	5.12	$123.37M	$24.09M
2023-06-30	6.51	$178.3M	$27.41M
2023-03-31	6.37	$207.47M	$32.58M
2022-12-31	5.64	$208.18M	$36.89M
2022-09-30	6.37	$253.83M	$39.88M
2022-06-30	7.46	$319.47M	$42.82M
2022-03-31	5.4	$246.8M	$45.73M
2021-12-31	5.44	$265.53M	$48.79M
2021-09-30	9.19	$405.68M	$44.12M
2021-06-30	8.88	$426.13M	$47.97M
2021-03-31	9.94	$437.14M	$43.98M
2020-12-31	113.96	$270.89M	$2.38M
2020-09-30	581.96	$86.71M	$149,000.00
2020-06-30	41.24	$55.23M	$1.34M
2020-03-31	20.12	$55.52M	$2.76M
2019-12-31	15.95	$73.13M	$4.59M
2019-09-30	12.63	$75.86M	$6.01M
2019-06-30	6.34	$43.8M	$6.91M
2019-03-31	80.01	$35.42M	$442,619.00
2018-12-31	11.46	$17.3M	$1.51M
2018-09-30	8.84	$22.04M	$2.49M
2018-06-30	6.65	$23.66M	$3.56M
2018-03-31	7.52	$35.73M	$4.75M
2017-12-31	5.05	$29.41M	$5.83M
2017-09-30	3.41	$24.81M	$7.28M
2017-06-30	4.49	$38.26M	$8.53M
2017-03-31	-8.21	$18.11M	-$2.2M
2016-12-31	-16.29	$12.31M	-$756,069.00
2016-09-30	37.95	$21.81M	$574,585.00
2016-06-30	-5.57	$22.09M	-$3.96M
2016-03-31	-325.56	$1.18B	-$3.61M
2015-12-31	-17.53	$34.72M	-$1.98M
2015-09-30	-309.03	$1.8B	-$5.82M
2015-06-30	-555.37	$3.27B	-$5.88M
2015-03-31	-858.1	$3.12B	-$3.63M
2014-12-31	-24,765.96	$2.48B	-$100,330.00
2014-09-30	-357.17	$2.83B	-$7.93M
2014-06-30	-648.57	$2.92B	-$4.51M
2014-03-31	-901.28	$2.83B	-$3.14M
2013-12-31	-496.8	$3.4B	-$6.83M
2013-09-30	-621.08	$3.49B	-$5.61M
2013-06-30	-902.13	$2.54B	-$2.82M
2013-03-31	-1,482.69	$2.77B	-$1.87M
2012-12-31	-391.33	$3.08B	-$7.87M
2012-09-30	-430.61	$4.06B	-$9.42M
2012-06-30	-359.55	$3.86B	-$10.73M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	50.5	$544.18M	$10.78M
2025-12-31	14.34	$401.91M	$28.02M
2024-12-31	16.73	$424.76M	$25.39M
2023-12-31	7.91	$167.39M	$21.17M
2022-12-31	5.64	$208.18M	$36.89M
2021-12-31	5.44	$265.53M	$48.79M
2020-12-31	113.96	$270.89M	$2.38M
2019-12-31	15.95	$73.13M	$4.59M
2018-12-31	11.46	$17.3M	$1.51M
2017-12-31	5.05	$29.41M	$5.83M
2016-12-31	-16.29	$12.31M	-$756,069.00
2015-12-31	-17.53	$34.72M	-$1.98M
2014-12-31	-24,765.96	$2.48B	-$100,330.00
2013-12-31	-496.8	$3.4B	-$6.83M
2012-12-31	-391.33	$3.08B	-$7.87M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Sight Sciences, Inc. (SGHT)	United States	$0.478B	-9.95
NeuroPace Inc (NPCE)	United States	$0.480B	-28.52
CARLSMED, INC. (CARL)	United States	$0.405B
Orthofix Medical Inc. (OFIX)		$0.373B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)	United States	$0.519B	27.16
CERUS CORP (CERS)	United States	$0.525B	-86.40
Orchestra BioMed Holdings, Inc. (OBIO)	United States	$0.356B	-4.39
SHOULDER INNOVATIONS, INC. (SI)	United States	$0.355B
DELCATH SYSTEMS, INC. (DCTH)	United States	$0.558B	820.33
Embecta Corp. (EMBC)	United States	$0.319B	2.10